Pediatric pulmonology
-
Pediatric pulmonology · Jan 2021
Meta AnalysisPediatric lung imaging features of COVID-19: A systematic review and meta-analysis.
Pediatric COVID-19 studies have been mostly restricted to case reports and small case series, which have prevented the identification of specific pediatric lung disease patterns in COVID-19. The overarching goal of this systematic review and meta-analysis is to provide the first comprehensive summary of the findings of published studies thus far describing COVID-19 lung imaging data in the pediatric population. ⋯ Chest CT manifestations in children with COVID-19 could potentially be used for early identification and prompt intervention in the pediatric population.
-
Pediatric pulmonology · Jan 2021
Meta AnalysisEfficacy and safety of EBUS-TBNA and EUS-B-FNA in children: A systematic review and meta-analysis.
Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) and transesophageal bronchoscopic ultrasound-guided fine-needle aspiration (EUS-B-FNA) are established modalities for evaluation of mediastinal/hilar lymphadenopathy in adults. Limited literature is available on the utility of these modalities in the pediatric population. Herein, we perform a systematic review and meta-analysis on the yield and safety of EBUS-TBNA and EUS-B-FNA in children. ⋯ EBUS-TBNA and EUS-B-FNA are safe modalities for evaluation of mediastinal lymphadenopathy in the pediatric population. EBUS-TBNA/EUS-B-FNA may be considered as the first-line diagnostic modalities for this indication, as they have a good diagnostic yield and can avoid the need for invasive diagnostic procedures.
-
Pediatric pulmonology · Jan 2021
Case ReportsBilateral pulmonary emboli in a teenager with positive SARS-CoV-2 antibody.
Thromboembolic phenomena, particularly pulmonary emboli, have been described in adult patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but have been less evident in children. We describe a case of a teenager with bilateral pulmonary emboli leading to cardiovascular collapse in the setting of a positive SARS-CoV-2 IgM antibody.